22.84
price up icon2.47%   0.55
after-market After Hours: 22.84
loading
Indivior Plc stock is traded at $22.84, with a volume of 2.56M. It is up +2.47% in the last 24 hours and up +47.64% over the past month. Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
See More
Previous Close:
$22.29
Open:
$22.26
24h Volume:
2.56M
Relative Volume:
1.09
Market Cap:
$2.78B
Revenue:
$1.12B
Net Income/Loss:
$5.00M
P/E Ratio:
2,284.00
EPS:
0.01
Net Cash Flow:
$-383.00M
1W Performance:
+4.77%
1M Performance:
+47.64%
6M Performance:
+132.35%
1Y Performance:
+84.42%
1-Day Range:
Value
$22.25
$23.16
1-Week Range:
Value
$21.48
$23.16
52-Week Range:
Value
$7.33
$23.16

Indivior Plc Stock (INDV) Company Profile

Name
Name
Indivior Plc
Name
Phone
804-379-1090
Name
Address
234 BATH ROAD, SLOUGH, BERKSHIRE
Name
Employee
1,164
Name
Twitter
Name
Next Earnings Date
2024-10-24
Name
Latest SEC Filings
Name
INDV's Discussions on Twitter

Compare INDV with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
INDV
Indivior Plc
22.84 2.78B 1.12B 5.00M -383.00M 0.01
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
149.77 66.04B 9.39B 2.61B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.63 45.57B 29.98B 958.27M 5.31B 0.2964
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.58 42.50B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.60 18.84B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
301.39 13.59B 2.99B 1.21B 1.13B 25.06

Indivior Plc Stock (INDV) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-06-25 Initiated H.C. Wainwright Buy
Jul-22-25 Resumed Jefferies Buy
Jan-28-25 Initiated Rodman & Renshaw Buy
Jul-23-24 Initiated Piper Sandler Overweight
Apr-03-24 Initiated Craig Hallum Buy
Jul-13-23 Initiated Northland Capital Outperform
View All

Indivior Plc Stock (INDV) Latest News

pulisher
Aug 12, 2025

Why is Indivior PLC stock going upStocks That Deliver Big Wins - news-j.co.kr

Aug 12, 2025
pulisher
Aug 10, 2025

What’s the beta of Indivior PLC stockMulti-Sector Diversified Watchlist - mustnews.co.kr

Aug 10, 2025
pulisher
Aug 09, 2025

| MarketBeat - MarketBeat

Aug 09, 2025
pulisher
Aug 08, 2025

The Street Loves This ‘Strong Buy’ Pharma Stock - MSN

Aug 08, 2025
pulisher
Aug 08, 2025

Indivior stock hits 52-week high at 22.36 USD - Investing.com

Aug 08, 2025
pulisher
Aug 08, 2025

Indivior stock hits 52-week high at 22.36 USD By Investing.com - Investing.com Nigeria

Aug 08, 2025
pulisher
Aug 08, 2025

Indivior initiated with a Buy at H.C. Wainwright - MSN

Aug 08, 2025
pulisher
Aug 07, 2025

US Judge Dismisses Securities Class Action Against Opioid Use Disorder Drugmaker Indivior - Law.com

Aug 07, 2025
pulisher
Aug 07, 2025

Indivior (INDV) Is Up 26.4% After Strong Q2 Profit and Raised 2025 Guidance - simplywall.st

Aug 07, 2025
pulisher
Aug 06, 2025

Indivior Beats Investor Suit Over Opioid Drug Sales Forecasts - Law360

Aug 06, 2025
pulisher
Aug 06, 2025

Indivior Gets Investor Claims Over Revenue From Two Drugs Tossed - Bloomberg Law News

Aug 06, 2025
pulisher
Aug 06, 2025

HC Wainwright Initiates Indivior at Buy With $28 Price Target - MarketScreener

Aug 06, 2025
pulisher
Aug 06, 2025

Suboxone Market Growth and Future Scope 2025-2032 | Indivior - openPR.com

Aug 06, 2025
pulisher
Aug 05, 2025

Indivior’s Strategic Turnaround Gains Traction Post-Q2 2025 (NASDAQ:INDV) - Seeking Alpha

Aug 05, 2025
pulisher
Aug 05, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 1, 2024 in Indivior PLC LawsuitINDV - ACCESS Newswire

Aug 05, 2025
pulisher
Aug 05, 2025

Levi & Korsinsky Notifies Indivior PLC Investors of a Class Action Lawsuit and Upcoming Deadline – INDV - ACCESS Newswire

Aug 05, 2025
pulisher
Aug 05, 2025

All You Need to Know About Indivior (INDV) Rating Upgrade to Strong Buy - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

Naloxone Market: Generated Opportunities and Future Scope 2025-2032 Featuring EMERGENT, Indivior PLC - openPR.com

Aug 05, 2025
pulisher
Aug 05, 2025

Best Momentum Stock to Buy for August 5th - The Globe and Mail

Aug 05, 2025
pulisher
Aug 05, 2025

New Strong Buy Stocks for August 5th: Aris Mining, Quad Graphics, Envista, Indivior, BJ's Restaurants - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

New Strong Buy Stocks for August 5th - The Globe and Mail

Aug 05, 2025
pulisher
Aug 05, 2025

Technical Bounce Expected in Indivior PLC Next WeekFree Stock Market Forecasting Tools - beatles.ru

Aug 05, 2025
pulisher
Aug 04, 2025

Indivior Plc (INDV) Jumps 22.8% on Impressive Earnings, Outlook - MSN

Aug 04, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Indivior PLC stockBreakthrough wealth creation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Indivior PLC stockRecord-breaking gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Indivior PLC stockBreakthrough profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Indivior PLC stockSuperior stock selection - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for Indivior PLCExceptional earning trajectories - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Indivior PLC stock compared to the marketUnprecedented growth rates - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Indivior PLC stockInvest in stocks with strong fundamentals - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is Indivior PLC company’s balance sheetUnstoppable trading performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Indivior PLC generate profit in a changing economyTurn market volatility into profit opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is Indivior PLC company’s growth strategyUnmatched profit growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Indivior (INDV) Is Up 22.8% After Strong Q2 Beat and Full-Year Revenue Outlook Raised Has the Bull Case Changed? - simplywall.st

Aug 03, 2025
pulisher
Aug 02, 2025

Is Indivior PLC stock overvalued or undervaluedDiscover market opportunities with expert help - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What markets is STT.PRG expanding into Is Indivior PLC stock a good long term investment option - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Indivior outlines $1.03B–$1.08B 2025 revenue guidance and cost structure overhaul through action agenda - MSN

Aug 02, 2025
pulisher
Aug 02, 2025

Indivior's Q2 2025: Navigating Contradictions in SUBLOCADE Growth, CJS Funding, and Market Dynamics - AInvest

Aug 02, 2025
pulisher
Aug 01, 2025

When is Indivior PLC stock expected to show significant growthAdvanced Screener Report With Low Risk - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

Trend Dashboard Flags Indivior PLC As Potential Swing TradeEntry Points For Growing Stocks Identified by Models - metal.it

Aug 01, 2025
pulisher
Aug 01, 2025

Indivior (INDV) Extends Jump on 3rd Day with 16% Gain - MSN

Aug 01, 2025
pulisher
Aug 01, 2025

Indivior PLC December 2026 Options Available for Trading - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

December 2026 Options Now Available For Indivior (INDV) - Nasdaq

Aug 01, 2025
pulisher
Aug 01, 2025

Indivior PLC Surpasses Analyst Target Price of $19.20/Share. - AInvest

Aug 01, 2025

Indivior Plc Stock (INDV) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$27.43
price up icon 3.35%
$17.43
price up icon 1.93%
drug_manufacturers_specialty_generic RDY
$13.91
price up icon 0.65%
$10.12
price up icon 2.64%
$128.89
price up icon 3.96%
$301.39
price up icon 0.32%
Cap:     |  Volume (24h):